Background: To address the issue of undiagnosed HIV infections, the Public Health Agency of Canada released the Human Immunodeficiency Virus-HIV Screening and Testing Guide in 2012, which identified several barriers and facilitators for HIV testing.
Introduction
Human immunodeficiency virus (HIV) infection is now largely considered a manageable condition due to advances in treatment. Without appropriate interventions, however, HIV can progress to acquired immune deficiency syndrome (AIDS), which can lead to illness and death. Reducing the spread of HIV in Canada requires concerted efforts at widespread screening and testing to identify individuals who may miss opportunities to obtain treatment, and thus unknowingly be transmitting the virus to others. Providing early HIV diagnosis is important in preserving quality of life for those who are infected, and reducing the number of undiagnosed cases of HIV will help to prevent transmission of the virus (1).
In Canada, approximately 75,500 individuals were living with HIV at the end of 2014 and an estimated 21% of those were unaware of their infection (2) . To complement existing initiatives to reduce the number of undiagnosed HIV cases in Canada, the Public Health Agency of Canada (the Agency) released the Human Immunodeficiency Virus-HIV Screening and Testing Guide (the Guide) in 2012 to support health care providers with normalizing HIV testing (1) . Within the Guide, several barriers and facilitators to HIV screening and testing were identified, specifically: lack of perceived risk for HIV infection among patients and providers; comfort and knowledge with respect to HIV testing among patients and providers; providers' time constraints; cumbersome consent procedures; and managing fears of stigma or discrimination associated with testing and risk behaviours in general (1) .
The studies used to inform the Guide were published prior to 2010 (1) . As the implementation and normalization of routine HIV screening and testing remain an important issue for public health in Canada, a broad overview of more recent studies on the barriers and facilitators of HIV testing was warranted. We chose to do an overview of the literature because the inconsistent definition of barriers and facilitators across studies as well as the overlap between barriers and facilitators limited the ability to perform a systematic review.
The objective of this overview was to summarize the most recent evidence regarding barriers and facilitators of HIV screening and testing in Canada, and similar developed countries in order to help identify gaps in knowledge, and potentially inform future revisions to the Guide.
Methods
A literature review was conducted using databases such as Scopus, PubMed (MEDLINE), and the Cochrane Library. Search terms included "HIV" or "human immunodeficiency virus" and "screening" or "testing" and "barriers" or "facilitators" or "predictors." Other literature sources searched for relevant reports included the websites of the Centers for Disease Control and Prevention (CDC), the European Centre for Disease Prevention and Control (ECDC), the Australian Department of Health, and the New Zealand Ministry of Health. Studies and reports from Canada, the United States, Europe, Australia, and New Zealand, published between 2010 and 2014, were included in the literature review; editorials, commentaries and letters to the editor were excluded. The key barriers and facilitators identified in each of the studies were reviewed and categorized, and evidence tables were developed to summarize and organize the key findings. The organization of study results into barrier and facilitator categories was confirmed by two of the authors of this article-S. Ha and T. Austin. Barriers and facilitators are described in Table 1 .
Table 1: Description of barriers and facilitators

Barriers Definition
Lack of perceived risk of HIV infection
For patients: the patient does not believe he/she has a risk of acquiring HIV, or believes that his/her behaviours prevent risk. For providers: the provider does not believe his/her patients have a risk of acquiring HIV, or assumes they are at low risk, and may also believe that HIV is not an issue for his/her patient population or region of practice.
Comfort discussing and lack of knowledge of HIV For patients: the patient does not feel comfortable discussing HIV or other sexual issues with the provider, and may have a general lack of knowledge about HIV, or how and where to get tested. For providers: the provider feels discomfort or anxiety in asking sexual questions to the patient, or in eliciting patient fears regarding HIV. He/she may lack knowledge of consent procedures, how to manage positive results and reporting procedures for their jurisdiction, and may feel that a lack of specific training prevents them from testing for HIV.
Health care provider time constraints
Health care providers have a lack of time for HIV testing and associated counselling, or have competing priorities during a visit that prevent them from testing for HIV.
Fear, stigma and discrimination
The patient fears a positive result, social repercussions for seeking testing or for testing positive (discrimination, rejection), being unable to cope with results, or that he/she will see someone he/she knows at the clinic.
Access to testing A lack of ability to access testing in general (due to remote/rural location, lack of insurance [U.S. studies], testing location hours of operation, language barriers), or an inability to access a variety of testing services that are typically available (e.g., lack of anonymous testing in rural locations vs. metropolitan locations) acts as a barrier to testing.
Financial and human resource constraints
Cases where providers may not perform HIV testing due to a lack of compensation, or there is an inability to run HIV testing initiatives due to lack of staff.
Facilitators Definition
Normalizing HIV testing Reducing the negative stigma surrounding HIV by making it a routine test (similar to checking cholesterol, for instance). Offering testing as part of regular care.
Opt-out testing HIV testing is offered and administered unless the patient specifically refuses.
Increasing knowledge and awareness
Using patient-centred educational material to make patients more knowledgeable, more likely to see HIV testing as a positive thing, and improve interest in testing.
Using provider-centred materials to enhance training around HIV testing, and improve provider-patient communication.
Results
Overall 34 studies and reports on barriers and facilitators to HIV testing were identified. The majority of these were American, while a smaller number were from European countries and Australia. One report and one study were from Canada; no literature was found from New Zealand.
Barriers
Lack of perceived risk of HIV infection
An important barrier to HIV testing is the perceived lack of risk that stems from the inability to accurately assess levels of risk, either for one's self (on the part of patients or clients) or for patients (on the part of health care providers), which has the potential to act as a barrier. In a systematic review of European studies by Deblonde et al., low risk perception was identified as a barrier in four (out of 24) of the studies analyzed (3) . In a survey of 629 Europeans recently diagnosed with HIV, 73% of respondents indicated that low risk perception was a reason for not having previously been tested (4) . A survey of 519 HIV-negative men in Australia found that 41.2% of respondents cited believing they had not engaged in risky behaviour as a reason for delaying or avoiding testing (5) . Similarly, several American interview-based studies have looked at barriers to initial testing in patients with HIV/AIDS, or factors that contributed to late diagnosis of HIV in individuals who developed AIDS within 12 months of HIV diagnosis (6−8).
Low risk perception is a recurring theme among these studies (6−8 
Health care provider time constraints
Time constraints and competing priorities during patient visits are commonly experienced by health care providers. Time constraints can arise due to lengthy consent procedures (depending on local regulations) as well as lengthy pre-and post-test counselling procedures (9,12,15,17,18,20,22,24). Health care providers may perceive time constraints as a barrier due to the lack of familiarity of local regulations (e.g., if they are unaware that testing requires only verbal consent, they may perceive the procedures required to obtain consent as being more time consuming than they actually are).
Fear, stigma and discrimination
When patients are fearful of positive results, they may be less likely to request an HIV test (3, 5, 25) . Thus, fear of the test itself or of potential positive results may act as a barrier, in addition to fears of being discriminated against or stigmatized. In recent literature, fear of stigma or discrimination from the community have emerged as barriers to HIV testing and may deter a patient from seeking HIV testing in the first place (25−27). In particular, this may be evident in small communities where the patient may be likely to encounter individuals he/she knows during the testing process (23). Patient fear of social repercussions due to a positive test is a very commonly mentioned barrier, both by patients and health care providers (4,7,9,11,22,26,28,29).
Patient fear regarding the possibility of disclosure or a lack of confidentiality is another barrier to HIV testing (3, 4, 27) . Youth may have particular reason to fear disclosure due to staff being unaware of testing confidentiality practices. In a study examining barriers to youth HIV testing in New York, of 131 HIV testing site representatives that were interviewed using a "secret shopper" approach, 14% either gave incorrect information, or did not know, when asked whether parents could find out the youth's test result (30). Fears with respect to anonymity likely also reflect fears regarding the stigma associated with testing and the potential discrimination from family or community members. Health care providers interviewed in one study suggested that assurances of confidentiality for the patients were of great importance as a facilitator (13). Patient fears related to stigma, consequences of positive results and confidentiality could also potentially stem from a lack of knowledge (e.g., a patient may not realize that they can live a long healthy life with current HIV treatments, in the case of a positive test), highlighting the overlap that can exist among barriers.
Access to testing
People living in rural or remote areas may not be able to access a variety of HIV testing services as easily as people living in denser metropolitan areas. Providers in Mississippi, for example, suggested that the need to travel long distances for testing services was a barrier for patients in their jurisdiction (11). In a separate U.S. study of individuals who received late diagnoses of HIV, living in a rural area was more commonly associated with late diagnoses than living in an urban area (31). Similarly, an Australian study found that having a practice in a metropolitan area was associated with more HIV testing than having a practice in a non-metropolitan area (OR=1.40) (32).
In a Canadian review of barriers faced by women with respect to HIV testing, the author stressed that anonymous testing may not be universally available (26). Among adolescents receiving rapid HIV testing in an emergency department (n=114), 80% of those surveyed stated they would be more likely to get a test if a rapid version was available (33). In the study by Hyden et al., in which 131 HIV testing site representatives in New York were interviewed, only 12% of the sites provided testing outside the hours of 08:30 to 17:00, Monday to Friday (30). Similarly, 23% of the sites exclusively offered testing on weekdays between 09:00 and 15:00. Thus, the operating hours of testing sites could represent a significant barrier to youth who are in school, as well as those who are unable to take time off work during the week. In a survey of Australian HIV-negative men, 15.2% of participants cited difficulty getting an appointment as a reason for delaying testing (5) . Health care providers have also identified that language barriers may also act as a barrier to accessing HIV testing (12,18,34).
Financial and human resource constraints
Health care providers frequently mentioned lack of resources or compensation as personal and institutional barriers. Having financial and physical resources, as well as being able to employ enough staff to run routine HIV testing initiatives within hospitals and community clinics, emerged as a barrier within American and European studies (3, 13, 14, 18, 20) . Health care providers have also cited a lack of compensation for the extra time spent on HIV testing and its related procedures as a barrier (9,11,22,23).
Due to the lack of recent Canadian studies in this area, it is not entirely clear whether these issues would emerge as barriers in Canada.
A summary of recent studies on barriers to HIV testing is presented in Appendix 1.
Facilitators
Normalizing HIV testing
The Agency, the CDC and the ECDC recommend normalizing HIV testing by including it as part of routine care (1, 22, 35) . Including HIV testing as a component of periodic routine medical care is a multi-faceted approach in the sense that normalized testing not only reduces the stigma associated with HIV, but also encourages more patients to be receptive to the idea of testing, and to be tested (1, 10, 16, 29, 33 Normalized testing has been linked to reduced stigma among patients who are tested for HIV. In a survey of Scottish men who have sex with men (MSM), individuals who had been tested in the past year had less fear of positive results, and a greater testing norm than those who had been tested more than one year ago, or had never been tested (36). Other studies suggest that "HIV should be no different than screening for glucose levels, cholesterol levels, or blood pressure" (17).
Opt-out testing
With opt-out testing, HIV testing is offered and administered, unless explicitly refused by the patient. Opt-out testing has been identified as a potential facilitator for HIV testing as it eliminates the requirement for lengthy consent procedures, removing this barrier for health care providers and patients. In this sense it addresses the issue of a lack of time, as well as concerns regarding any lack of reimbursement for extra time spent. Although opt-out testing could be effective in increasing testing rates (3), it is important that patients have the capacity to consent and understand the implications of an HIV test. Some provinces and territories in Canada have already adopted an opt-out strategy to prenatal HIV screening (26).
Increasing knowledge and awareness
Increasing the availability of HIV-related knowledge translation material to improve awareness could be useful to highlight the benefits of testing. When patients are educated about the benefits of testing and are educated with respect to HIV (for instance, regarding the effectiveness of antiretroviral therapies and methods for reducing transmission risk), they are more likely to be tested (34). Adam et al. found that greater HIV knowledge was associated with better testing routines among MSM (37). Studies examining the predictors of HIV testing suggest that individuals are more likely to seek testing if they foresee positive outcomes (e.g., protecting family, peace of mind) as opposed to negative ones (e.g., stigma) (29,37). Studies examining facilitators or factors associated with recent HIV testing suggest that increasing patient and health care provider knowledge using HIV literature and HIV-specific training is a potential facilitator (13,17,23). Health care providers found that patient interest and willingness, as well as knowledge of local consent and counselling regulations were facilitators to testing (13,23).
Not surprisingly, health care providers suggest improvement in HIV-specific training for providers, increased availability of HIV literature for providers and patients, patient education initiatives, and improvements in provider communication as possible facilitators of routine HIV testing (13,17,23). The Guide recommends "[streamlining] the provision of pre-test information using print, video, mobile and web-based resources" (1).
A summary of recent studies of facilitators of HIV testing is presented in Appendix 2.
Discussion
Our overview of the recent literature confirmed the ongoing importance of all the barriers that were identified in the HIV Screening and Testing Guide: lack of perceived risk, lack of comfort or knowledge, provider time constraints, and fear, stigma, and discrimination. Additional barriers identified in this review include fears regarding disclosure or a lack of confidentiality, lack of access, lack of compensation for providers, and the lack of human resources to carry out testing initiatives.
In terms of facilitators, while the Guide does recommend the normalization of HIV screening and testing, and touches upon the topic of increasing awareness (e.g., by emphasizing HIV as a chronic manageable condition), little is mentioned regarding opt-out testing as a potential facilitator (1). Opt-out testing was identified as a facilitator in this overview, as it addresses some key barriers. Although it is currently used in some parts of Canada as part of prenatal screening, it is unclear whether opt-out testing for the general population will result in significant improvements in identifying HIV-positive individuals.
A strength of the current overview is that it provides a brief snapshot of what has been learned about barriers and facilitators of HIV screening and testing since the creation of the Guide in 2012. A limitation of this overview is that it only included studies from high-income countries. This may limit global generalizability of the results, but they remain relevant for Canada. Also, there was no systematic assessment of bias performed for the included studies. This overview, however, is intended to provide a snapshot of the evidence, as opposed to grading the quality of that evidence.
This study has identified a number of areas for future work. First, these findings could be used to inform future iterations of the Guide, and could be used by other organizations to inform programming. Second, while it is important to identify and be aware of important barriers, more research could be performed to review and evaluate interventions aimed at addressing these barriers (e.g., knowledge translation products, campaigns, etc.). Third, HIV testing strategies such as couples testing and self-testing were not identified as facilitators in the current review. Future research could consider the merits of these strategies. Finally, overall there was a lack of Canadian studies; thus, studies to confirm the relevance of the above-mentioned barriers and facilitators in the Canadian context would be useful.
Conclusion
Understanding the major barriers and facilitators to HIV testing is essential to increase the number of individuals being tested for HIV as it can inform effective strategies to decrease the 21% of those infected who are unaware of their HIV status (2) . Targeted interventions could address the barriers and capitalize on the facilitators. 
